DE602005004026D1 - Einen transkriptionsfaktor kodierendes humanes prädispositionsgen für autismus sowie dessen verwendungen - Google Patents

Einen transkriptionsfaktor kodierendes humanes prädispositionsgen für autismus sowie dessen verwendungen

Info

Publication number
DE602005004026D1
DE602005004026D1 DE602005004026T DE602005004026T DE602005004026D1 DE 602005004026 D1 DE602005004026 D1 DE 602005004026D1 DE 602005004026 T DE602005004026 T DE 602005004026T DE 602005004026 T DE602005004026 T DE 602005004026T DE 602005004026 D1 DE602005004026 D1 DE 602005004026D1
Authority
DE
Germany
Prior art keywords
autism
gene
diagnosis
disorder
well
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005004026T
Other languages
English (en)
Other versions
DE602005004026T2 (de
Inventor
Anne Philippi
Francis Rousseau
Peter Brooks
Joerg Hager
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IntegraGen SA
Original Assignee
IntegraGen SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IntegraGen SA filed Critical IntegraGen SA
Publication of DE602005004026D1 publication Critical patent/DE602005004026D1/de
Application granted granted Critical
Publication of DE602005004026T2 publication Critical patent/DE602005004026T2/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE602005004026T 2004-07-01 2005-06-30 Einen transkriptionsfaktor kodierendes humanes prädispositionsgen für autismus sowie dessen verwendungen Active DE602005004026T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US58413004P 2004-07-01 2004-07-01
US584130P 2004-07-01
PCT/IB2005/002319 WO2006003520A2 (en) 2004-07-01 2005-06-30 Human autism predisposition gene encoding a transcription factor and uses thereof

Publications (2)

Publication Number Publication Date
DE602005004026D1 true DE602005004026D1 (de) 2008-02-07
DE602005004026T2 DE602005004026T2 (de) 2008-12-24

Family

ID=35432082

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005004026T Active DE602005004026T2 (de) 2004-07-01 2005-06-30 Einen transkriptionsfaktor kodierendes humanes prädispositionsgen für autismus sowie dessen verwendungen

Country Status (10)

Country Link
US (1) US20070218068A1 (de)
EP (1) EP1761649B1 (de)
JP (1) JP4949240B2 (de)
AT (1) ATE382101T1 (de)
AU (1) AU2005258838B2 (de)
CA (1) CA2571365A1 (de)
DE (1) DE602005004026T2 (de)
ES (1) ES2299059T3 (de)
IL (1) IL179751A (de)
WO (1) WO2006003520A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011509096A (ja) * 2008-01-09 2011-03-24 イエール ユニバーシティ 特発性自閉症のリスク増加に関連するコンタクション関連タンパク質２（ｃｎｔｎａｐ２）の突然変異
WO2009150221A1 (en) * 2008-06-12 2009-12-17 Integragen A method for autism prediction
AU2009313999B2 (en) * 2008-11-12 2016-09-29 Lineagen, Inc. Autism associated genetic markers
WO2011067296A1 (en) 2009-12-01 2011-06-09 Integragen A combination of eight risk alleles associated with autism
KR101167942B1 (ko) 2010-02-12 2012-07-23 차의과학대학교 산학협력단 Ａｌｇ12 유전자로부터 유래된 단일염기다형을 포함하는 폴리뉴클레오티드, 이를 포함하는 마이크로어레이 및 진단키트, 및 이를 이용한 자폐 스펙트럼 장애 분석방법
EP2566977A1 (de) 2010-05-04 2013-03-13 Integragen Neue kombination aus acht risikoallelen im zusammenhang mit autismus
US10900080B2 (en) 2011-02-24 2021-01-26 The Chinese University Of Hong Kong Molecular testing of multiple pregnancies
CN111808943B (zh) * 2020-06-18 2021-07-20 重庆浦洛通基因医学研究院有限公司 一种精神类个体化用药基因检测方法

Also Published As

Publication number Publication date
US20070218068A1 (en) 2007-09-20
AU2005258838B2 (en) 2009-05-14
JP2008504837A (ja) 2008-02-21
EP1761649A2 (de) 2007-03-14
IL179751A0 (en) 2007-05-15
ES2299059T3 (es) 2008-05-16
DE602005004026T2 (de) 2008-12-24
WO2006003520A2 (en) 2006-01-12
WO2006003520A3 (en) 2006-03-02
EP1761649B1 (de) 2007-12-26
CA2571365A1 (en) 2006-01-12
JP4949240B2 (ja) 2012-06-06
ATE382101T1 (de) 2008-01-15
IL179751A (en) 2011-01-31
AU2005258838A1 (en) 2006-01-12

Similar Documents

Publication Publication Date Title
DE602005004026D1 (de) Einen transkriptionsfaktor kodierendes humanes prädispositionsgen für autismus sowie dessen verwendungen
MY164376A (en) Phosphospecific antibodies recognizing tau
MX2008009947A (es) Composiciones farmaceuticas que comprenden dextrometorfano y quinidina para el tratamiento de depresion, ansiedad y trastornos neurodegenerativos.
JO3076B1 (ar) نظم العلاج المناعي المعتمد على حالة apoe
MX354662B (es) Anticuerpos fosfoespecificos que reconocen la tau.
DE602006019296D1 (de) Pyrimidinylamidverbindungen, die die durch vla-4 vermittelte leukozytenadhäsion inhibieren
WO2006087634A3 (en) Uses of human autism susceptibility gene encoding a kinase
IL179831A0 (en) Human autism susceptibility gene encoding prkcb1 and uses thereof
BRPI0509477A (pt) compostos de sulfonamida para o tratamento de distúrbios neurodegenerativos
DK1656458T3 (da) Human autisme-susceptibilitetsgen og anvendelser deraf
UA86399C2 (ru) Применение 2,5 дигидроксибензолсульфоновой кислоты для изготовления лекарства, которые применяют для лечения болезней, зависимых от ангиогенеза
BR112012022255A2 (pt) composição farmaceuticaestabilizada
GB2473579A (en) Stat3 and TYK2 as drug targets for neurodegenerative diseases
IL185868A0 (en) Human autism susceptibility gene encoding a transmembrane protein and uses thereof
WO2006090288A3 (en) Human autism susceptibility genes encoding a neurotransmitter transporter and uses thereof
WO2001020025A3 (en) Polymorphisms in the human cyp3a4 and cyp3a7 genes and their use in diagnostic and therapeutic applications
WO2008070311A3 (en) Gene expression profiling of parkinson's disease
WO2006003526A3 (en) Human autism susceptibility gene encoding otoa and uses thereof
DE602005016244D1 (de) Benzoxazolonderivate, verfahren zu deren herstellung und deren anwendungen
ATE443160T1 (de) Für einen spannungsgesteuerten kaliumkanal kodierendes humanes adipositas- suszeptibilitätssgen und dessen verwendung
WO2011015646A3 (en) Furan-imidazolone derivatives, for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders
WO2008070284A3 (en) Amyloid beta peptides and methods of uses thereof
AU3925701A (en) Polymorphisms in the human cyp2b6 gene and their use in diagnostic and therapeutic applications
TW200801190A (en) Regulators of protein misfolding and aggregation and methods of using the same
TH74680B (th) คลอไรท์ในการรักษาโรคการเสื่อมของประสาท

Legal Events

Date Code Title Description
8364 No opposition during term of opposition